Science Policy Roundup: December 8, 2017 ?>

Science Policy Roundup: December 8, 2017

ASBMB members urge Congress to remove graduate student tax from the final tax reform effort

So far, 1,013 ASBMB members have sent 3,106 letters to 369 members of Congress in a push to ensure that the repeal of the graduate student tuition tax waiver does not make it onto the final tax reform bill. The bill is in conference committee, as the House and Senate negotiators are amending the legislation to ensure passage through both chambers. Take action here.

Episode 2 of “Pipettes and Politics” is available

The ASBMB public affairs staff released its second episode of “Pipettes and Politics”, a science policy podcast discussing issues affecting the research community. The episode also features a conversation with Matt Hourihan of the American Association for the Advancement of Science. Read more here, and listen to the podcast on iTunes, Stitcher or Soundcloud.

Recap of ASBMB meetings with federal agency officials

Public Affairs Advisory Committee member Rick Page summarizes discussions from meetings with leaders at the National Institutes of Health and the National Science Foundation. The meetings serve as important foundation for future interaction with these offices. Read more here.

Congress passes continuing resolution, avoiding government shutdown.

The U.S. House and Senate passed a continuing resolution to fund the government until Dec. 22. Although the threat of government shutdown was averted this week, Congress will have to pass legislation to fund the government into the new year. The continuing resolution uses fiscal 2017 funding levels to temporarily fund the government until a budget is passed for FY18. Read more here.

U.S. House health subcommittee receives update on 21st Century Cures Act

Science Policy Analyst André Porter summarizes a hearing by the U.S. House Energy and Commerce Committee to update Congress on the implementation of 21st Century Cures Act. The hearing included testimony from Francis S. Collins, director of the National Institutes of Health. Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *